Your browser doesn't support javascript.
loading
Experience with sotrovimab treatment of SARS-CoV-2-infected patients in Denmark.
Rasmussen, Line Dahlerup; Lebech, Anne-Mette; Øvrehus, Anne; Poulsen, Birgitte Klindt; Christensen, Hanne Rolighed; Nielsen, Henrik; Johansen, Isik Somuncu; Omland, Lars Haukali; Wiese, Lothar; Helleberg, Marie; Storgaard, Merete; Dalager-Pedersen, Michael; Rasmussen, Thomas A; Benfield, Thomas; Petersen, Tonny Studsgaard; Andersen, Åse Bengård; Gram, Mie Agermose; Stegger, Marc; Edslev, Sofie Marie; Obel, Niels.
Afiliação
  • Rasmussen LD; Department of Infectious Disease, Odense University Hospital, Odense C, Denmark & Research Unit for Infectious Diseases, University of Southern Denmark, Odense, Denmark.
  • Lebech AM; Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Øvrehus A; Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Poulsen BK; Department of Infectious Disease, Odense University Hospital, Odense C, Denmark & Research Unit for Infectious Diseases, University of Southern Denmark, Odense, Denmark.
  • Christensen HR; Department of Clinical Pharmacology, Aalborg University Hospital, Aalborg, Denmark.
  • Nielsen H; Department of Clinical Pharmacology, Copenhagen University Hospital, Copenhagen, Denmark.
  • Johansen IS; Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark.
  • Omland LH; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Wiese L; Department of Infectious Disease, Odense University Hospital, Odense C, Denmark & Research Unit for Infectious Diseases, University of Southern Denmark, Odense, Denmark.
  • Helleberg M; Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Storgaard M; Department of Infectious Diseases, Zealand University Hospital Roskilde, Denmark.
  • Dalager-Pedersen M; Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Rasmussen TA; Center of excellence for Health Immunity & Infections, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
  • Benfield T; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
  • Petersen TS; Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark.
  • Andersen ÅB; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Gram MA; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
  • Stegger M; Doherty Institute for Infection and Immunity, University of Melbourne, Australia.
  • Edslev SM; Department of Infectious Diseases, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark.
  • Obel N; Department of Clinical Pharmacology, Copenhagen University Hospital, Copenhagen, Denmark.
Br J Clin Pharmacol ; 89(6): 1820-1833, 2023 06.
Article em En | MEDLINE | ID: mdl-36519217
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Pregnancy País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Pregnancy País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article